Final Programme - iuphar

More documents

Recommendations

Info

FC16 Natural products: Past and future? Thu 325 Inhibition of prostate cell growth and angiogenesis induced by different phytosterols of marine origin Silvia Novio, (Spain), M Freire-Garabal, G Amigo, MJ Nuñez-Iglesias Thu 326 Evaluating the anti-diabetic properties of Paspalum vaginatum Nkechi Veronica Offiah, (Trinidad & Tobago), CD Ezeokoli Thu 327 The study of antidiabetic effects of partially purified extract from the roots of Thottea grandiflora Rottb Patrick Okechukwu, (Malaysia), G Marimuthu, GA Akuwoah Thu 328 Antimalaria and anticancer properties of Labisia pumila Maizatul Hasyima Omar, (UK), A Crozier, NR Abdullah, Z Ismail Thu 329 Effects of ibogaine on rat uterus contraction and antioxidative enzymes activity Zorana Orescanin-Dusic, (Republic of Serbia), M Slavic, R Paskulin, P Jamnik, S Milovanovic, M Spasic, D Blagojevic Thu 330 In vivo evaluation of the antitumor activity of daphnetin in murine melanoma model Fausto AJ Orozco, (Mexico), MJ García Mondragón, A Maldonado Espinza, MA Herrera Henriquez, N Mendoza Patiño, JJ Mandoki Weitzner Thu 331 Chinese herbal medicine ‘Wu Ling San’ had anti-inflammatory activity in crystal induced nephritis in rats Yoko Oyama, (Japan), S Tancharoen, T Ito, T Hashiguchi, T Uchimura, K Kawahara, I Maruyama Thu 332 Antioxidant effect of a methanol extract of Garcinia kola biflavonoid agbilu Jones Chukwudi Ozokwere, (South Africa), F Udoh, B Lawal, E Olivier Thu 333 Study of antidepressant activity of portulaca oleracea linn in mice Vinod Pawar, (India), S Gujar, S Rayate, RN Patil, S Hugar Thu 334 Acute and subacute toxicity of virgin coconut oil in rodents Ryan Pekson, (The Philippines), I Sia Thu 335 Optimization of aristolochic acid I detection in Aristolochia tagala Cham and Thai traditional recipe using TLC Rattana Phadungrakwittaya, (Thailand), P Akarasereenont, A Lumlerdkij, S Chaisri, S Chotewuttakorn, T Laohapand Thu 336 Membrane with a vegetative extract based on the collagen for tissue regeneration Guram Pichkhadze, (Kazakhstan), G Ustenova, I Kaulambaeva, D Assylbekova Thu 337 Cannabidiol inhibits human cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 Robert Ramer, (Germany), J Merkord, B Hinz Thu 338 Intraperitoneal and oral LD50 of an active principle of Nigella sativa, thymoquinone, in mice and rats Muhammad Akram Randhawa, (Saudi Arabia), A Al-Ali, AA Alkhawajah, NA Shaikh Thu 339 Regulatory status of herbal medicines. Considerations about Cuba Diadelis Remirez-Figueredo, (Cuba) Thu 340 Analysing on compatibility principle of pharmacologic action of traditional Chinese medicine formula by network approach Junguo Ren, (PR China), X Ma, C Lin, H Li, M Wang, J Li, Y Wang, J Liu 304 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC16 Natural products: Past and future? Thu 341 Bak foong pills, a traditional remedy for dysmenorrhoea, inhibits nociception via the somatostatin pathway Dewi K Rowlands, (PR China), YG Cui, SC So, LL Tsang, YW Chung, HC Chan Thu 342 Protective effect of Nigella sativa extract and thymoquinone on serum/glucose deprivation-induced PC12 cells death Hamid Reza Sadeghnia, (Iran), SH Mousavi, Z Tayarani-Najaran, M Asghari Thu 343 Effect of anchusan, Japanese traditional herbal medicine, on midazolam metabolism in rats Yusuke Saito, (Japan), Y Nishimura, N Kurata, M Iwase, H Yasuhara Thu 344 San'oshashinto prevents cardiac ischemia/reperfusion injury in ovariectomized rat via antioxidant properties Mayuko Sakanashi, (Japan), T Matsuzaki, K Noguchi, J Nakasone, M Sakanashi, K Chinen, M Sakanashi, M Tsutsui Thu 345 Effect of momordica charantia on blood glucose level in experimentally induced diabetic rats Mahmed Salahuddin, (Bangladesh) Thu 346 Effect of three plants: Hypericum humifusum, Crataegus L. Azarolus and Myrtus Communis L. on ischemia-reperfusion liver in Wistar male rats I Salouage, H Ferchichi, T Ayadi, S Bacha, I Ouanes, M Lakhal, Anis Klouz (Tunisia) Thu 347 Antioxidant activity of Rhizophora mangle (L.) bark and its effect on redox mechanisms involved in wound healing J Sánchez Calero, R Faure García, G Martínez Sánchez, O Fernández Limia, M Mitjavila Cors, E Marrero Faz, Yinet Barrese-Pérez, (Cuba) Thu 348 Selective detection of CYP3A4 inhibition by complementary products Danielle Sevior, (Finland), J Hokkanen, A Tolonen, K Abass, L Tursas, O Pelkonen, J Ahokas Thu 349 The “Zinaxin” clinical – pharmacological application aspects Evgeniya Shikh, (Russian Federation), O Shumkova Thu 350 Cinnamomi ramulus ethanol extract exerts vasorelaxation through inhibition of the rho-kinase signalling pathway Heung Shin, (South Korea), Y Kang Thu 351 Solavetivone reduces intracellular calcium in cultured myocytes isolated from guinea-pig ileum Joelmir LV Silva, (Brazil), F De Andrade Cavalcante, VLC Rigoni, TMS Silva, TL Nascimento, J Aboulafia, BA Silva, VLA Nouailhetas Thu 352 Trachylobane-360 decreases intracellular calcium in cultured myocytes isolated from guinea-pig ileum Joelmir LV Silva, (Brazil), RF Santos, VLS Rigoni, JJF Tavares, MS Silva, TL Nascimento, J Aboulafia, BA Silva, VLA Nouailhetas Thu 353 Crotalus durissus terrificus snake venom: a potential natural product in controlling inflammatory diseases Tatiane Soares de Lima, (Brazil), S Coccuzzo Sampaio, MC Cirillo Thu 354 On future phytopharmacology Jakob Stiglmayr, (Germany), J Milbradt, E Neu, SK Gupta, J Foltinova, M Schratz, W Seidenbusch, G Weber, N Senn, R Neu, U Welscher, M Michailov Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 305
Page 1:
of basic and clinical pharmacology
Page 4 and 5:
Congress patron 2 HRH Crown Princes
Page 6 and 7:
Congress President Kim Brøsen Secr
Page 8 and 9:
General information Registration &
Page 10 and 11:
Banks, currency & credit cards The
Page 12 and 13:
Information to presenters ■ The a
Page 14 and 15:
Hotel Bella Center Copenhagen Groun
Page 16 and 17:
Programme at a glance Time Hall A2
Page 18 and 19:
16 General events General events Op
Page 20 and 21:
Programme outline Plenary lectures
Page 22 and 23:
FC10 Drugs for half the world: Paed
Page 24 and 25:
Tue 12:45 W13 Workshop: Novel perip
Page 26 and 27:
W01 Pharmacology of adrenoceptors:
Page 28 and 29:
W02 Symposium on advances in GI pha
Page 30 and 31:
W04 Symposium: Antioxidants as ther
Page 32 and 33:
Plenary lectures PL01 Plenary lectu
Page 34 and 35:
FC02 Transmembrane transport: Persp
Page 36 and 37:
FC04 Pharmacoepidemiology, current
Page 38 and 39:
FC06 The heart gone wrong: Stabiliz
Page 40 and 41:
FC09 Inflammation and immunopharmac
Page 42 and 43:
Page 44 and 45:
SS01 Sponsored symposium Sponsored
Page 46 and 47:
W06 Workshop. Effect of disease on
Page 48 and 49:
W08 Workshop. Identifying targets f
Page 50 and 51:
W10 Workshop. Innovative Medicines
Page 52 and 53:
FC01 Clinical pharmacology in the e
Page 54 and 55:
FC03 Ion channels in analgesia and
Page 56 and 57:
FC05 Translational science in the m
Page 58 and 59:
Page 60 and 61:
FC08 Development in the treatment o
Page 62 and 63:
Plenary lectures PL04 Plenary lectu
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
FC07 Simulation and data modelling
Page 72 and 73:
Page 74 and 75:
W12 Workshop. Experimental pain met
Page 76 and 77:
W14 Workshop. Translating the human
Page 78 and 79:
W15 Workshop. The IUPHAR initiative
Page 80 and 81:
W17 Workshop. Standards for PhD Edu
Page 82 and 83:
W19 Workshop. Influence of degenera
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
FC08 Development in the treatment o
Page 92 and 93:
PL10 ASPET Plenary Lecture Chair: T
Page 94 and 95:
Page 96 and 97:
FC12 Ion channelopathies: New windo
Page 98 and 99:
FC14 Addiction and doping: Neurobio
Page 100 and 101:
FC17 New approaches and targets in
Page 102 and 103:
W04 Symposium: Antioxidants as ther
Page 104 and 105:
W21 Workshop. Inflammation - here,
Page 106 and 107:
W23 Workshop. Applying pharmacogeno
Page 108 and 109:
W25 Workshop. High science in the l
Page 110 and 111:
W27 Workshop. Approaches to medicin
Page 112 and 113:
FC11 G protein-coupled 7TM receptor
Page 114 and 115:
FC13 Maximising benefits and minimi
Page 116 and 117:
FC15 Endothelium in Health and dise
Page 118 and 119:
Page 120 and 121:
FC18 Nuclear receptor targets for t
Page 122 and 123:
PL16 Plenary Lecture Supported by a
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
FC15 Endothelium in Health and dise
Page 130 and 131:
Page 132 and 133:
W28 Workshop. The Boehringer-Ingelh
Page 134 and 135:
W30 Workshop. Is eNOS still a valid
Page 136 and 137:
W32 Workshop. The good, the bad and
Page 138 and 139:
W34 Workshop. State-of-the-art of b
Page 140 and 141:
FC10 Drugs for half the world: Pedi
Page 142 and 143:
Page 144 and 145:
FC14 Addiction and doping: Neurobio
Page 146 and 147:
FC16 Natural products: Past and fut
Page 148 and 149:
FC18 Nuclear receptor targets for t
Page 150 and 151:
PL22 Plenary Lecture Chair: Zhi-Bin
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
FC15 Endothelium in health and dise
Page 158 and 159:
Page 160 and 161:
158
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
W12 Experimental pain methods in de
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
FC06 The heart gone wrong; stabiliz
Page 180 and 181:
Page 182 and 183:
FC08 Developments in the treatment
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
W03 Targeting TRP channels for pain
Page 196 and 197:
W19 Influence of degeneration and r
Page 198 and 199:
W19 Influence of degeneration and r
Page 200 and 201:
W20 Pharmacology education for a su
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
FC06 The heart gone wrong; stabiliz
Page 216 and 217:
Page 218 and 219:
FC08 Developments in the treatment
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
FC19 General session Tue 361 Analge
Page 232 and 233:
FC19 General session - Biologics Tu
Page 234 and 235:
FC19 General session - Haematology
Page 236 and 237:
FC19 General session - oncology Tue
Page 238 and 239:
FC19 General session - oncology Tue
Page 240 and 241:
FC19 General session - Toxicology T
Page 242 and 243:
Page 244 and 245:
W11 New opportunities in the pharma
Page 246 and 247:
W23 Applying pharmacogenomics (PGX)
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257: FC13 Maximising benefits and minimi
Page 260 and 261: FC14 Addiction and doping: Neurobio
Page 262 and 263: FC15 Endothelium in health and dise
Page 268 and 269: W30 Is eNOS Still a valid therapeut
Page 270 and 271: FC16 Natural products: Past and fut
Page 276 and 277: FC17 New approaches and targets in
Page 280 and 281: W34 State-of-the-art of basic and c
Page 282 and 283: FC10 Drugs for half the world: Paed
Page 284 and 285: FC11 G protein-coupled 7TM receptor
Page 294 and 295: W29 New horizons in therapeutic dru
Page 296 and 297: FC14 Addiction and doping: Neurobio
Page 314 and 315: FC18 Nuclear receptor targets for t
Page 316 and 317: 314 Index Name Paper ref. Name Pape
Page 356 and 357:
354 Index Name Paper ref. Name Pape
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
382 Notes Notes
Page 386:
Final Programme printed in Singapor
show all

Final Programme - iuphar

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?